Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Dianne J. Beveridge"'
Autor:
Dianne J. Beveridge, Kirsty L. Richardson, Michael R. Epis, Rikki A. M. Brown, Lisa M. Stuart, Andrew J. Woo, Peter J. Leedman
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract RNA-based therapeutics are emerging as innovative options for cancer treatment, with microRNAs being attractive targets for therapy development. We previously implicated microRNA-642a-5p (miR-642a-5p) as a tumor suppressor in prostate cancer
Externí odkaz:
https://doaj.org/article/cb9118786c3647f78f95a546270cae69
Autor:
Andrew J. Woo, Peter J. Leedman, Michael R. Epis, Lisa M. Stuart, Kirsty L. Richardson, Dianne J. Beveridge, Rikki A. M. Brown
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
RNA-based therapeutics are emerging as innovative options for cancer treatment, with microRNAs being attractive targets for therapy development. We previously implicated microRNA-642a-5p (miR-642a-5p) as a tumor suppressor in prostate cancer (PCa), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e135fc59066acd4bc5d6cf2fc9c7d2
https://doaj.org/article/cb9118786c3647f78f95a546270cae69
https://doaj.org/article/cb9118786c3647f78f95a546270cae69
Autor:
Peter J. Leedman, Andrew J. Woo, Kirsty L. Richardson, Dianne J. Beveridge, Tasnuva D. Kabir, Lisa M. Stuart
Publikováno v:
Cancer Research. 81:2379-2379
Hepatocellular carcinoma (HCC) is increasing in incidence, has a very poor prognosis and presents massive global unmet clinical need. Current treatment of advanced HCC with sorafenib and other targeted therapies offers short-term relief with little s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2560885a9c21d203269818ddc2acb11
https://doi.org/10.1158/1538-7445.am2021-2379
https://doi.org/10.1158/1538-7445.am2021-2379
Autor:
Kirsty L. Richardson, Jacqueline M. Bentel, Keith M. Giles, Michael R. Epis, Peter J. Leedman, Lisa M. Stuart, Patrick A. Candy, Ronald J. Cohen, Dianne J. Beveridge
Publikováno v:
Oncotarget
// Michael R. Epis 1, * , Keith M. Giles 1, 4, * , Dianne J. Beveridge 1, * , Kirsty L. Richardson 1 , Patrick A. Candy 1 , Lisa M. Stuart 1 , Jacqueline Bentel 2 , Ronald J. Cohen 5 and Peter J. Leedman 1, 3 1 Laboratory for Cancer Medicine, Harry P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aafae4829adaa98f152e3fd1e353929
https://doi.org/10.18632/oncotarget.18664
https://doi.org/10.18632/oncotarget.18664
Autor:
Larissa C. Wintle, Lisa M. Stuart, Kirsty L. Richardson, Tasnuva D. Kabir, Rikki A. M. Brown, Michael R. Epis, Peter J. Leedman, Marisa H. De Pinho, Felicity C. Kalinowski, Jessica L. Horsham, Dianne J. Beveridge
Publikováno v:
MicroRNA and Cancer ISBN: 9781493974337
MicroRNAs (miRNAs) are a family of short noncoding RNA molecules that fine-tune expression of mRNAs. Often their altered expression is associated with a number of diseases, including cancer. Given that miRNAs target multiple genes and "difficult to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a198651cd141a5966a0449f469945c
https://doi.org/10.1007/978-1-4939-7435-1_12
https://doi.org/10.1007/978-1-4939-7435-1_12
Autor:
Jacob George, Larissa C. Wintle, Michael R. Epis, Felicity C. Kalinowski, Vishal Chaturvedi, Rikki A. M. Brown, Kirsty L. Richardson, Patrick A. Candy, Peter J. Leedman, Dianne J. Beveridge, Clarissa Ganda, Christina Kopp, Tasnuva D. Kabir, George C.T. Yeoh, Lisa M. Stuart
Publikováno v:
Hepatology (Baltimore, Md.). 67(1)
Sorafenib remains the only approved drug for treating patients with advanced hepatocellular carcinoma (HCC). However, the therapeutic effect of sorafenib is transient, and patients invariably develop sorafenib resistance (SR). Recently, TYRO3, a memb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05660c155662334f1aad8c5fc6aa74c
https://pubmed.ncbi.nlm.nih.gov/28833396
https://pubmed.ncbi.nlm.nih.gov/28833396
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 103:58-62
Both hepatic and renal regeneration are associated with rapid increases in hepatocyte growth factor (HGF)mRNA levels, not only in the regenerating tissue, but also in the lung. In this study, changes in the levels of HGF mRNA in the terminal ileum an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c710b391d717cfecdb6717b654f3270
https://doi.org/10.1055/s-0029-1211330
https://doi.org/10.1055/s-0029-1211330
Autor:
Peter J. Leedman, Melissa A. Brown, Stacey L. Edwards, Jodi M. Saunus, Andrew D. Davidson, Glenn Francis, Dianne J. Beveridge, Juliet D. French, Sarah A. Wagner, Esme C. Hatchell, Sandra Stein, Kaylene J. Simpson
Publikováno v:
Cancer Research. 68:9469-9478
BRCA1 is a breast cancer susceptibility gene that is down-regulated in a significant proportion of sporadic breast cancers. BRCA1 is posttranscriptionally regulated by RNA-binding proteins, the identities of which are unknown. HuR is an RNA binding p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d03d4a8c6e6a3058558c267729889ce
https://doi.org/10.1158/0008-5472.can-08-1159
https://doi.org/10.1158/0008-5472.can-08-1159
Autor:
Henry Furneaux, Keith M. Giles, Andrew M. Thomson, Dominic C. Voon, John M. Daly, Dianne J. Beveridge, Peter J. Leedman, Jalal A. Jazayeri
Publikováno v:
Journal of Biological Chemistry. 278:2937-2946
Despite promoting growth in many cell types, epidermal growth factor (EGF) induces growth inhibition in a variety of cancer cells that overexpress its receptor. The cyclin-dependent kinase inhibitor p21(WAF1) is a central component of this pathway. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f5b6334c3d2f69cf9a9936232d62ef
https://doi.org/10.1074/jbc.m208439200
https://doi.org/10.1074/jbc.m208439200
Autor:
Jalal A. Jazayeri, Caroline E Walker, Andrew M. Thomson, Dianne J. Beveridge, Peter J. Leedman, Lois Balmer
Publikováno v:
Molecular and Cellular Biology. 21:2070-2084
The epidermal growth factor (EGF) receptor (EGF-R) is a protein tyrosine kinase receptor that is the target for high-affinity ligands, such as EGF and transforming growth factor alpha. EGF-R shares extensive homology with the erbB oncogene product of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ff69336c2ff634651b827177d7dbb0
https://doi.org/10.1128/mcb.21.6.2070-2084.2001
https://doi.org/10.1128/mcb.21.6.2070-2084.2001